Evolution of Pulsed Oxygen Saturation During Interval Training Compared to Continuous Training in COPD Patients
1 other identifier
observational
12
1 country
1
Brief Summary
A problem often observed during exercise training is oxygen desaturation exclusively during exercise in some patients. In the case of exercise-induced desaturation, it may be suggested to train these patients in interval training to limit exercise-induced desaturation. Interval training consists of alternating active phases of short duration (often 30 seconds to 1 minute) followed by a short active or passive recovery phase of equivalent duration to the previous phase. Investigators therefore hypothesise that interval training on a cycloergometer or treadmill can limit exercise-induced desaturation in COPD patients. The aim of the study is to observe the evolution of pulsed oxygen saturation between a continuous training session and a interval training session.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2023
CompletedStudy Start
First participant enrolled
January 10, 2023
CompletedFirst Posted
Study publicly available on registry
April 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2025
CompletedJanuary 21, 2026
January 1, 2026
2.7 years
January 10, 2023
January 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in oxygen pulsed saturation
Difference in minimum saturation during both exercise, the measurement will be performed with a pulse oximeter (Spirodoc, MIR)
One week
Secondary Outcomes (7)
Difference in oxygen pulsed saturation
One week
Difference in peripheral muscle oxygenation
One week
Difference in respiratory rate
One week
Difference in tidal volume
One week
Difference in inspiratory capacity
One week
- +2 more secondary outcomes
Study Arms (2)
Continuous training session
Interval Training session
Interventions
Interval training consists of a 5-minute warm-up, a 5-minute cool-down and 20 minutes of alternating 60 seconds of high-intensity work (100% of the maximum power recorded in the incremental test that was carried out when the patient was admitted to the pulmonary rehabilitation department) and 60 seconds of unloaded pedalling or rest.
Continuous training consists of a 5 minute warm up, 5 minute cool down and 20 minutes of moderate intensity work. The workload is set at 60% of the patient's maximum power
Eligibility Criteria
Patients with COPD who meet the inclusion criteria will be offered to participate in this study during a pulmonary rehabilitation programme which will take place in the pneumology rehabilitation department of the Le Havre Hospital. If the patient wishes to participate in the study, he/she will be given an information note containing a declaration of non-opposition which he/she will have to complete and sign.
You may qualify if:
- a diagnosis of COPD
- participating in a pulmonary rehabilitation programme
- with an exercise-induced desaturation less than 90%
- no oxygen supplementation
You may not qualify if:
- Under 18 years of age
- Pregnant woman
- Person not affiliated to a health insurance regime or not benefiting from a social security regime
- Patient under curatorship, guardianship or safeguard of justice
- Patient speaking a language other than French
- Patient with severe hypoxaemia (SpO2 ≤ 80%) during exercise
- Patient having had a moderate or severe exacerbation (hospitalisation for respiratory reasons) in the previous 4 weeks
- Patients with orthopaedic, rheumatic, vascular or neurological pathology limiting their ability to make an effort
- Breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medrinal Clementcollaborator
- Combret Yanncollaborator
- Machefert Margauxcollaborator
- Groupe Hospitalier du Havrelead
Study Sites (1)
Groupe Hospitalier du Havre
Le Havre, Normandy, 76290, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume Prieur, PT, PhD
Groupe Hospitalier du Havre
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 10, 2023
First Posted
April 24, 2023
Study Start
January 10, 2023
Primary Completion
September 30, 2025
Study Completion
October 10, 2025
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, CSR
- Time Frame
- after publication
- Access Criteria
- the request shall be sent to Guillaume Prieur (gprieur.kine@gmail.com)
deidentified participtant data